Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals
12 months ago
In
Biopharma Manufacturing
Innovation
Leaders
Pharma Industry Updates
Clarity Pharmaceuticals Reports Positive Topline Phase II SABRE Trial Data for SAR-Bombesin Diagnostic in Breast Cancer
1 year ago
In
Biopharma Manufacturing
Breakthroughs
Clinical Trials
FDA Approvals
Industry Conferences
Innovation
Leaders
Research Updates
Venture Capital
June Pharma Highlights: Vaccine Panel Shake-up, Moderna Deal Fallout, and FDA’s AI Adoption
1 year ago
In
Featured Analysis
Innovation
Leaders
Pharma Industry Updates
Major Biotech M&A and Global Partnerships Drive Mid-Year Industry Realignment
1 year ago
In
Deals
Innovation
Leaders
Partnerships
Pharma Industry Updates
Research Updates
Hillchol Oral Cholera Vaccine Shows Promise in Phase III Trial in India
1 year ago
In
Clinical Trials
Innovation
Leaders
Trodelvy plus Keytruda Shows Promise in First-Line PD-L1+ Triple-Negative Breast Cancer
1 year ago
In
Clinical Trials
Innovation
Leaders
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
In
Investments
Leaders
Partnerships
MAIA Biotechnology Sets Its Sights on Bold Cancer Immunotherapy Milestones for 2025
1 year ago
In
Breaking News
FDA Approvals
Leaders
Research Updates
Top Stories
FDA Leadership Change Sparks Industry Concern as Pharma Navigates Regulatory Challenges
1 year ago
In
Biopharma Highlights
Innovation
Leaders
Pharma Industry Updates
EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders
1 year ago
In
Breaking News
Leaders
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
1 year ago
In
Deals
Investments
Leaders
People
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
1 year ago
In
AI & Data
Industry Conferences
Innovation
Investments
Leaders
People
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage
1 year ago
In
Industry Conferences
Leaders
People
Novartis Accelerates Stroke Prevention Strategy with $3.1B Acquisition of Anthos
1 year ago
In
Deals
Leaders
Research Updates
FDA Approves First Oral Therapy for Severe Eczema in Adolescents
1 year ago
In
Biopharma Highlights
Breaking News
FDA Approvals
Leaders
Funding Surge Fuels Innovation: Verdiva, Aviceda, Windward, and Colossal Secure Big Series Rounds in January
1 year ago
In
Biopharma Highlights
Breakthroughs
Deals
Funding Rounds
Leaders
Venture Capital
Sarepta’s Gene Therapy Elevidys Shows Positive Phase III Results in Duchenne Muscular Dystrophy
1 year ago
In
AI & Data
Clinical Trials
Innovation
Leaders
GSK’s Jemperli Receives EMA Approval for First-Line Endometrial Cancer Treatment
1 year ago
In
Clinical Trials
Featured Analysis
Leaders
Pharma Industry Updates
FDA Approves Datopotamab Deruxtecan (Datroway) for HR-Positive, HER2-Negative Breast Cancer
1 year ago
In
FDA Approvals
Innovation
Leaders
Research Updates
Denali, Agios, Cabaletta and Walden Drive Rare Disease and Immuno-Innovations into the Spotlight at JP Morgan Week
1 year ago
In
Breaking News
Breakthroughs
Industry Conferences
Leaders
People
Top Stories
NHS Launches World-First AI Tool to Predict Type 2 Diabetes Risk From ECG Readings
1 year ago
In
Innovation
Leaders
FDA Awards RMAT Designation to Mesoblast’s Cell Therapy for Heart Defect, Paving the Way for Pediatric Innovation
1 year ago
In
Biopharma Highlights
FDA Approvals
Leaders
Pharma Industry Updates
Top Stories
Pragmatic Trials, Real-World Impact: NIH’s 2024 Push to Redefine Clinical Research
2 years ago
In
Breakthroughs
Featured Analysis
Leaders
Top Stories
Atezolizumab Shows Promise in Rare Thyroid Cancer: Roche’s Immunotherapy Gains Ground in RET-Altered Tumors
2 years ago
In
Clinical Trials
Leaders
Research Updates
Driving Innovation and Navigating Complexity in 2024
2 years ago
In
Leaders
